Innovation – Open view page
General information
Innovation ID | 555 |
Version ID | 425 |
Innovation Title | Chickpea inbred variety ICCV 97114 for cultivation in low to mid-altitudes in Malawi |
Innovation description | ICCV 97114 is a medium duration desi chickpea variety that flowers in 52 - 54 days and matures in 120 – 125 days. It is adapted to low to medium rainfall areas with strong biotic stress resistance. Grain yield estimates from field tests range from of 2.2 to 2.8 mt/ha, with grains high in protein. This variety will potentially contribute to SDG`s 1,2,3,13, and 17. |
Reporting Staff | NVPR Ganga Rao (ICRISAT) |
Year (Reporting) | 2020 |
Reporting status | Approved |
Innovation Type | Genetic (variety and breeds) |
Number of varieties | 1 |
Stage reached
Stage of Innovation | Stage 3: available/ ready for uptake |
Year (Stage) | 2020 |
Stage Description | This variety was released on July 4, 2020 for cultivation in Malawi with potential spillover effects in Tanzania. |
Has a lead organization | yes |
Lead Organization | Ministry of Agriculture Irrigation and Water Development, Department of Agricultural Research Services |
Top 5 contributors | International Crops Research Institute for the Semi-Arid Tropics |
Contributions and mapping
All partners | |
Main CRP | |
Flagship project | |
Cluster | |
Other CRPs-Flagships-Clusters | CGIAR Research Program on Grain Legumes and Dryland Cereals,FP4-Variety and Hybrid Development,FP4-3-Product testing and release |
Scope
Geographic scope | National |
Regions | |
Countries | Malawi,United Republic of Tanzania |
Targeted outcomes
Main Sub-IDO | Enhanced genetic gain |
Other Sub-IDO | Closed yield gaps through improved agronomic and animal husbandry practices |
Other Sub-IDO | Reduced production risk |
Evidences
Evidences | List of varieties released by ICRISAT (GLDC-mapped) 2020 from MEASURE Platform [https://mel.cgiar.org/uploads/relatedfiles/jhF3fH3GLzIx9UvsOqbzlMPwA0MDgf.xlsx] |
Linked Elements
Milestones | 6814-172-37920 - New suite of resilient varieties released by NARS partners. (Phase 1 investments start being released) |
Outcome Impact Case |
Policy |